References
- Kullo K.J., Gau G.T. and Tajik J. : Novel risk factors for atherosclerosis. Mayo Clin Proc 2000 ; 75 : 369-380.
- Webb NR, Moore KJ. Macrophage-derived foam cells in atherosclerosis : lessons from murine models and implications for therapy. Curr Drug Targets. 2007 ; 8(12) : 1249-63.
- Rios FJ, Koga MM, Ferracini M, Jancar S. Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. PLoS One. 2012 ; 7(5) : e36632.
- Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest. 2009 ; 19(1) : 136-45.
- Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006 ; 4(3) : 211-21. https://doi.org/10.1016/j.cmet.2006.06.007
- Tojo N, Asakura E, Koyama M, Tanabe T, Nakamura N. Effects of macrophage colony-stimulating factor (M-CSF) on protease production from monocyte, macrophage and foam cell in vitro : a possible mechanism for anti-atherosclerotic effect of M-CSF. Biochim Biophys Acta. 1999 ; 1452(3) : 275-84. https://doi.org/10.1016/S0167-4889(99)00127-5
- van der Kooij MA, Morand OH, Kempen HJ, van Berkel TJ. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol. 1996 ; 16(1) : 106-14. https://doi.org/10.1161/01.ATV.16.1.106
- James E. McLaren, Daryn R. Michael, Tim G. Ashlin, Dipak P. Ramji. Cytokines, macrophage lipid metabolism and foam cells : Implications for cardiovascular disease therapy. Progress in Lipid Research 2011 ; 50 : 331-347. https://doi.org/10.1016/j.plipres.2011.04.002
- Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004 ; 15(4) : 237-54. https://doi.org/10.1016/j.cytogfr.2004.03.004
- Ehrenwald, E., and P. L. Fox. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J. Clin. Invest. 1996 ; 97 : 884-890. https://doi.org/10.1172/JCI118491
- Rozenberg,O., et al. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress : studies in PON1-knockout mice. Free Radic. Biol. Med. 2003 ; 34 : 774-784. https://doi.org/10.1016/S0891-5849(02)01429-6
- Carr, A.C., M. R. McCall, and B. Frei. Oxidation of LDL by myeloperoxidase and reactive nitrogen species : reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 2000 ; 20 : 1716-1723. https://doi.org/10.1161/01.ATV.20.7.1716
- Rydberg, E. K., et al. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler. Thromb. Vasc. Biol. 2004 ; 24 : 2040-2045. https://doi.org/10.1161/01.ATV.0000144951.08072.0b
- Sakashita, T. et al. Essential involvement of 12-lipoxygenase in regio specific and stereospecific oxidation of low density lipoprotein by macrophages. Eur. J. Biochem. 1999 ; 265 : 825-831. https://doi.org/10.1046/j.1432-1327.1999.00803.x
- Cathcart, M. K. Regulation of superoxide anion production by NADPH oxidase in monocytes/ macrophages : contributions to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004 ; 24 : 23-28. https://doi.org/10.1161/01.ATV.0000097769.47306.12
- Xu, W., et al. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase. J. Biol. Chem. 2001 ; 276 : 36454-36459. https://doi.org/10.1074/jbc.M105093200
- Li, Q., and M. K. Cathcart. Selective inhibition of cytosolic phospholipase A2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation. J. Biol. Chem. 1997 ; 272 : 2404-2411. https://doi.org/10.1074/jbc.272.4.2404
- 完譯中藥大辭典, 정담, p2622-2632, 1999
- Kim SY, Yun-Choi HS. Platelet anti-aggregating activities of bupleurumin from the aerial parts of Bupleurum falcatum. Arch Pharm Res. 2007 ; 30(5) : 561-4. https://doi.org/10.1007/BF02977649
- Chen YL, Lin SZ, Chang JY, Cheng YL, Tsai NM, Chen SP, Chang WL, Harn HJ. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Biochem Pharmacol. 2006 ; 72(3) : 308-19. https://doi.org/10.1016/j.bcp.2006.04.031
- Nakahara Y, Okawa M, Kinjo J, Nohara T. Oleanene glycosides of the aerial parts and seeds of Bupleurum falcatum and the aerial parts of Bupleurum rotundifolium, and their evaluation as anti-hepatitis agents. Chem Pharm Bull (Tokyo). 2011 ; 59(11) : 1329-39. https://doi.org/10.1248/cpb.59.1329
- 이준무, 이은, 최무영. 시호(Bupleuri Radix)분말이 고콜레스테롤 급여 흰쥐의 체지질구성 및 TBARS 량에 미치는 영향. 대한본초학회지, 2000 ; 15(1) : 67-71
- Hazen S.L. and Heinecke J.W. : 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalysed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99, 2075, 1997 https://doi.org/10.1172/JCI119379
- Leuwenburg C., Rasmussrn J.E. and Hsu F.F : Mass spectrometric quantitation of marker for protein oxidation by tyrosyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997 ; 272 : 3520. https://doi.org/10.1074/jbc.272.6.3520
-
Hashizume M, Mihara M. Cytokine. Atherogenic effects of TNF-
${\alpha}$ and IL-6 via up-regulation of scavenger receptors. 2012 ; 58(3) : 424-30. https://doi.org/10.1016/j.cyto.2012.02.010 - Park JG, Oh GT. The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep. 2011 ; 44(8) : 497-505. https://doi.org/10.5483/BMBRep.2011.44.8.497
- Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones. 2007 ; 39(2) : 86-93
- Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res. 2003 ; 93(4) : 280-91. https://doi.org/10.1161/01.RES.0000087541.15600.2B